Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Oct 1;158(10):1021-1022.
doi: 10.1001/jamasurg.2023.2856.

Will Targeted Axillary Surgery Suffice for Adjuvant Treatment Decision-Making?

Margaret S Pichardo  1 , Jennifer Q Zhang  2   3 , Oluwadamilola M Fayanju  2   3   4   5
Affiliations
Comment

Will Targeted Axillary Surgery Suffice for Adjuvant Treatment Decision-Making?

Margaret S Pichardo et al. JAMA Surg. .
No abstract available

PubMed Disclaimer

Comment on

  • Association of Axillary Dissection With Systemic Therapy in Patients With Clinically Node-Positive Breast Cancer.
    Weber WP, Matrai Z, Hayoz S, Tausch C, Henke G, Zimmermann F, Montagna G, Fitzal F, Gnant M, Ruhstaller T, Muenst S, Mueller A, Lelièvre L, Heil J, Knauer M, Egle D, Sávolt Á, Heidinger M, Kurzeder C; TAXIS Study Writing Group; Zwahlen DR, Gruber G, Ackerknecht M, Kuemmel S, Bjelic-Radisic V, Smanykó V, Vrieling C, Satler R, Hagen D, Becciolini C, Bucher S, Simonson C, Fehr PM, Gabriel N, Maráz R, Sarlos D, Dedes KJ, Leo C, Berclaz G, Fansa H, Hager C, Reisenberger K, Singer CF, Loibl S, Winkler J, Lam GT, Fehr MK, Kohlik M, Clerc K, Ostapenko V, Maggi N, Schulz A, Andreozzi M, Goldschmidt M, Saccilotto R, Markellou P. Weber WP, et al. JAMA Surg. 2023 Oct 1;158(10):1013-1021. doi: 10.1001/jamasurg.2023.2840. JAMA Surg. 2023. PMID: 37466971 Free PMC article. Clinical Trial.

References

    1. Weber WP, Matrai Z, Hayoz S, et al.; TAXIS Study Writing Group. Association of axillary dissection with systemic therapy in patients with clinically node-positive breast cancer. JAMA Surg Published online July 19, 2023. doi:10.1001/jamasurg.2023.2840 - DOI - PMC - PubMed
    1. Caudle AS, Yang WT, Krishnamurthy S, et al. Improved axillary evaluation following neoadjuvant therapy for patients with node-positive breast cancer using selective evaluation of clipped nodes: implementation of targeted axillary dissection. J Clin Oncol. 2016;34(10):1072–1078. doi:10.1200/JCO.2015.64.0094 - DOI - PMC - PubMed
    1. Henke G, Knauer M, Ribi K, et al. Tailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS): study protocol for a multicenter, randomized, phase 3 trial. Trials. 2018;19(1):667. doi:10.1186/s13063-018-3021-9 - DOI - PMC - PubMed
    1. Kuemmel S, Heil J, Rueland A, et al. A prospective, multicenter registry study to evaluate the clinical feasibility of targeted axillary dissection (TAD) in node-positive breast cancer patients. Ann Surg. 2022;276(5):e553–e562. doi:10.1097/SLA.0000000000004572 - DOI - PubMed